• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2010 年至 2015 年美国牙医的阿片类药物处方行为:理赔数据告诉了我们什么?

Opioid prescribing practices from 2010 through 2015 among dentists in the United States: What do claims data tell us?

出版信息

J Am Dent Assoc. 2018 Apr;149(4):237-245.e6. doi: 10.1016/j.adaj.2018.01.005.

DOI:10.1016/j.adaj.2018.01.005
PMID:29599017
Abstract

BACKGROUND

Dentists wrote 6.4% of all opioid prescriptions in the United States in 2012. The purpose of this study was to examine opioid prescription rates, dosage of opioids prescribed, type of opioid drug prescribed, and type of dental visit at which dentists prescribe opioids.

METHODS

The authors used the 2010 through 2015 Truven Health Marketscan Research databases and the Prescription Drug Monitoring Program (PDMP) Training and Technical Assistance Center conversion data set. The authors conducted descriptive analyses for days' supply, quantity prescribed, and daily morphine milligram equivalent dose.

RESULTS

The opioid prescription rate per 1,000 dental patients increased from 130.58 in 2010 to 147.44 in 2015. Approximately 68.41% of all opioids prescribed were during surgical dental visits and approximately 31.10% during nonsurgical dental visits. During nonsurgical dental visits at which dentists prescribed an opioid, most of the procedures were restorative.

CONCLUSIONS

Among a population of dental patients with private insurance, opioid prescribing rates in the United States increased slightly from 2010 to 2015. The largest increase was among 11- through 18-year-olds. Almost one-third of opioid prescriptions written by dentists were associated with nonsurgical dental visits.

PRACTICAL IMPLICATIONS

Use of PDMP resources and use of nonopioid analgesics could help reduce the number of opioid prescriptions in dentistry.

摘要

背景

2012 年,美国牙医开具了所有阿片类药物处方的 6.4%。本研究的目的是检查牙医开具阿片类药物处方的比例、开出的阿片类药物剂量、所开阿片类药物的类型以及开具阿片类药物的牙科就诊类型。

方法

作者使用了 2010 年至 2015 年 Truven Health Marketscan 研究数据库和处方药物监测计划(PDMP)培训和技术援助中心转换数据集。作者对供应天数、处方数量和每日吗啡毫克当量剂量进行了描述性分析。

结果

每千名牙科患者的阿片类药物处方率从 2010 年的 130.58 增加到 2015 年的 147.44。大约 68.41%的阿片类药物是在牙科手术就诊时开具的,大约 31.10%是在非手术牙科就诊时开具的。在牙医开具阿片类药物的非手术牙科就诊中,大多数手术是修复性的。

结论

在美国,在有私人保险的牙科患者中,从 2010 年到 2015 年,阿片类药物的处方率略有上升。增幅最大的是 11 至 18 岁人群。牙医开具的三分之一以上的阿片类药物处方与非手术牙科就诊有关。

实践意义

利用 PDMP 资源和使用非阿片类镇痛药可能有助于减少牙科的阿片类药物处方数量。

相似文献

1
Opioid prescribing practices from 2010 through 2015 among dentists in the United States: What do claims data tell us?2010 年至 2015 年美国牙医的阿片类药物处方行为:理赔数据告诉了我们什么?
J Am Dent Assoc. 2018 Apr;149(4):237-245.e6. doi: 10.1016/j.adaj.2018.01.005.
2
Multiple opioid prescriptions among privately insured dental patients in the United States: Evidence from claims data.美国私人保险牙科患者的多种阿片类药物处方:来自索赔数据的证据。
J Am Dent Assoc. 2018 Jul;149(7):619-627.e1. doi: 10.1016/j.adaj.2018.02.025. Epub 2018 Apr 12.
3
Overprescribing of Opioids to Adults by Dentists in the U.S., 2011-2015.美国牙医 2011-2015 年给成年人开出的阿片类药物处方过多。
Am J Prev Med. 2020 Apr;58(4):473-486. doi: 10.1016/j.amepre.2019.11.006. Epub 2020 Feb 4.
4
Opioid prescribing patterns after dental visits among beneficiaries of Medicaid in Washington state in 2014 and 2015.2014 年和 2015 年,华盛顿州医疗补助受益人群在看牙后开具阿片类药物的情况。
J Am Dent Assoc. 2019 Apr;150(4):259-268.e1. doi: 10.1016/j.adaj.2018.12.030.
5
Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.受控物质处方模式 - 处方行为监测系统,八个州,2013 年。
MMWR Surveill Summ. 2015 Oct 16;64(9):1-14. doi: 10.15585/mmwr.ss6409a1.
6
Trends in national opioid prescribing for dental procedures among patients enrolled in Medicaid.医疗保险患者中牙科手术阿片类药物处方的国家趋势。
J Am Dent Assoc. 2021 Aug;152(8):622-630.e3. doi: 10.1016/j.adaj.2021.04.013.
7
Opioid prescribing by dentists in Manitoba, Canada: A longitudinal analysis.加拿大曼尼托巴省牙医的阿片类药物处方:一项纵向分析。
J Am Dent Assoc. 2019 Feb;150(2):122-129. doi: 10.1016/j.adaj.2018.10.024.
8
Comparison of Opioid Prescribing by Dentists in the United States and England.美国和英国牙医开具阿片类药物处方的比较。
JAMA Netw Open. 2019 May 3;2(5):e194303. doi: 10.1001/jamanetworkopen.2019.4303.
9
Prescription Drug Monitoring Program Use: National Dental PBRN Results.处方药监测计划的使用:全国牙科初级保健研究网络的结果。
JDR Clin Trans Res. 2019 Apr;4(2):178-186. doi: 10.1177/2380084418808517. Epub 2018 Oct 29.
10
A longitudinal cohort study of opioid prescriptions associated with nonsurgical dental visits among Oregon and New York state Medicaid beneficiaries, 2014-2016.2014 - 2016年俄勒冈州和纽约州医疗补助受益人与非手术牙科就诊相关的阿片类药物处方纵向队列研究。
J Am Dent Assoc. 2022 May;153(5):460-469. doi: 10.1016/j.adaj.2021.10.011. Epub 2022 Feb 10.

引用本文的文献

1
Barriers to dental providers' use of a clinical decision support tool for pain management following tooth extractions.牙科医疗服务提供者在拔牙后使用疼痛管理临床决策支持工具的障碍。
Implement Res Pract. 2025 Feb 9;6:26334895251319810. doi: 10.1177/26334895251319810. eCollection 2025 Jan-Dec.
2
Rural-urban differences in dental opioid prescribing among adolescent/young adult and adult Medicaid beneficiaries.城乡青少年/成年 Medicaid 受益人群中牙科阿片类药物处方的差异。
Front Public Health. 2024 Oct 17;12:1465206. doi: 10.3389/fpubh.2024.1465206. eCollection 2024.
3
Acute Pain Management Following Mandibular Third Molar Exodontia: A Bibliometric Analysis of Randomized Controlled Trials.
下颌第三磨牙拔除后的急性疼痛管理:随机对照试验的文献计量分析
Int Dent J. 2025 Apr;75(2):939-948. doi: 10.1016/j.identj.2024.09.018. Epub 2024 Oct 6.
4
Evidence-based clinical practice guideline for the pharmacologic management of acute dental pain in adolescents, adults, and older adults: A report from the American Dental Association Science and Research Institute, the University of Pittsburgh, and the University of Pennsylvania.青少年、成年和老年人群急性牙痛的药物治疗循证临床实践指南:美国牙科协会科学研究所、匹兹堡大学和宾夕法尼亚大学的报告。
J Am Dent Assoc. 2024 Feb;155(2):102-117.e9. doi: 10.1016/j.adaj.2023.10.009.
5
Association between the COVID-19 outbreak and opioid prescribing by U.S. dentists.美国牙医与 COVID-19 爆发相关的阿片类药物处方的关联。
PLoS One. 2023 Nov 2;18(11):e0293621. doi: 10.1371/journal.pone.0293621. eCollection 2023.
6
Evidence-based clinical practice guideline for the pharmacologic management of acute dental pain in children: A report from the American Dental Association Science and Research Institute, the University of Pittsburgh School of Dental Medicine, and the Center for Integrative Global Oral Health at the University of Pennsylvania.循证临床实践指南:儿童急性牙痛的药物治疗管理,美国牙科协会科学研究所、匹兹堡大学牙医学院和宾夕法尼亚大学全球综合口腔健康中心联合发布。
J Am Dent Assoc. 2023 Sep;154(9):814-825.e2. doi: 10.1016/j.adaj.2023.06.014.
7
De-Implementing Opioids for Dental Extractions (DIODE): a multi-clinic, cluster-randomized trial of clinical decision support strategies in dentistry.停用阿片类药物用于拔牙(DIODE):一项在牙科中评估临床决策支持策略的多诊所、集群随机试验。
Implement Sci. 2023 Feb 10;18(1):5. doi: 10.1186/s13012-023-01262-7.
8
Association Between State Opioid Prescribing Limits and Duration of Opioid Prescriptions From Dentists.州阿片类药物处方限制与牙医开具阿片类药物处方时长之间的关联
JAMA Netw Open. 2023 Jan 3;6(1):e2250409. doi: 10.1001/jamanetworkopen.2022.50409.
9
Launching an innovative educational model addressing substance use disorders and dental pain management (Project ECHO® in dentistry).启动一个创新的教育模式,以解决物质使用障碍和牙科疼痛管理问题(ECHO 在牙科项目)。
BMC Oral Health. 2022 Sep 15;22(1):402. doi: 10.1186/s12903-022-02417-6.
10
The feasibility of academic detailing for acute oral pain management in outpatient dentistry: A pilot study.学术细化在口腔门诊急性口腔疼痛管理中的可行性:一项试点研究。
J Am Pharm Assoc (2003). 2023 Jan-Feb;63(1):158-163.e6. doi: 10.1016/j.japh.2022.08.001. Epub 2022 Aug 5.